• Updates and Advances in Cancer Detection

    This week’s Innovation Partners BioBlog focuses on advances in cancer detection and screening. A new blood test identifies eight cancer types that account for 60% or more deaths from cancer each year, while a non-invasive blood test may hold promise for colorectal cancer screening. This and more in this week’s BioBlog. Liquid Biopsy Test Shows ...

  • Merck, Humana, Teva, and Government Health Regulations in the News

    In this week’s Innovation Partners BioBlog, we share updates from companies such as Humana, Merck, and Teva. Humana has chosen to exit industry trade group AHIP, while Teva and Merck announce updates on important new drugs. This and more in this week’s Innovation Partners BioBlog. Congressional Advisory Group Supports Changes In Medicare Doctor Payments The ...

  • Cancer Risks, Treatment, and Drugs in the News

    This week’s Innovation Partners BioBlog spotlights cancer risks, treatment, and drugs in the news. A new study out of China that assessed nearly 4 million women working long-term night shifts found an increased risk of cancer. New medications are on the horizon, while the J.P. Morgan Healthcare Conference begins in San Francisco. This week’s headlines ...

  • Cancer Care and Treatment in the Spotlight This Week

    Cancer deaths have dropped to their lowest rate since 1991, mostly in part to fewer Americans smoking. This week’s BioBlog is filled with more good news from the world of oncology and cancer treatment, including advances in the treatment of breast cancer, renal cell carcinoma, squamous cell carcinoma, and brain tumors. FDA Clears Stereotactic Radiotherapy ...

  • A Look at the Top Health News Stories of 2017 and More

    2017 was a year of many landmarks, including the highest NMEs approved in any year except 1996. It was a year of many milestones in the war on cancer and a year in which the contentious fight over healthcare, insurance, and who pays for it continued in Congress. A look at these and other top ...